{
  "doc_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e",
  "total_chunks": 6,
  "chunks": [
    {
      "chunk_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e_chunk_000_2611d37c",
      "doc_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e",
      "chunk_index": 0,
      "text": "# Extendicare## PROCEDURE**MANUAL:** Infection Prevention and Control\n**INDEX:** IPC6-P10.05\n**SECTION:** Multi-Drug-Resistant Organisms (MDROs)\n**DESCRIPTION:** Carbapenemase-Producing Enterobacteriales (CPE)\n**APPROVED BY:** Chief Medical Officer\n**EFFECTIVE DATE:** February 18, 2025\n**REVIEWED DATE:** February 11, 2025\n**MODIFIED DATE:** May 30, 2025----# POLICY## Multi-Drug-Resistant Organisms (MDROs)### PROCEDURE#### Screening\n- Ensure that, prior to admission, the completed application has been reviewed for any history of CPE and forwarded to the Infection Control Professional/Designate if there is history of infection, colonization or exposure. - Ensure that the appropriate physician/nurse practitioner’s order and laboratory test forms are completed if required.",
      "char_count": 779,
      "token_estimate": 194,
      "section_title": null,
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e_chunk_001_c4ab5634",
      "doc_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e",
      "chunk_index": 1,
      "text": "# Extendicare## PROCEDURE**MANUAL:** Infection Prevention and Control\n**INDEX:** IPC6-P10.05\n**SECTION:** Multi-Drug-Resistant Organisms (MDROs)\n**DESCRIPTION:** Carbapenemase-Producing Enterobacteriales (CPE)\n**APPROVED BY:** Chief Medical Officer\n**EFFECTIVE DATE:** February 18, 2025\n**REVIEWED DATE:** February 11, 2025\n**MODIFIED DATE:** May 30, 2025----# POLICY## Multi-Drug-Resistant Organisms (MDROs)### PROCEDURE#### Screening\n- Ensure that, prior to admission, the completed application has been reviewed for any history of CPE and forwarded to the Infection Control Professional/Designate if there is history of infection, colonization or exposure. - Ensure that the appropriate physician/nurse practitioner’s order and laboratory test forms are completed if required. - Testing sites include:\n- Stool or rectal swab (stained with feces)\n- And if indicated:\n- Urine\n- Wounds\n- Exit sites of all indwelling devices such as catheter or gastrostomy tube\n- Testing of contacts and exposures should include a minimum of 3 sets of specimens taken on different days, with at least one taken 21 days after last exposure.#### Management\n- Place a resident with a suspect/confirmed case, exposure, or a confirmed history of CPE (either through infection or colonization) on Contact Precautions as required.",
      "char_count": 1307,
      "token_estimate": 326,
      "section_title": null,
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e_chunk_002_9863158c",
      "doc_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e",
      "chunk_index": 2,
      "text": "- Ensure that the appropriate physician/nurse practitioner’s order and laboratory test forms are completed if required. - Testing sites include:\n- Stool or rectal swab (stained with feces)\n- And if indicated:\n- Urine\n- Wounds\n- Exit sites of all indwelling devices such as catheter or gastrostomy tube\n- Testing of contacts and exposures should include a minimum of 3 sets of specimens taken on different days, with at least one taken 21 days after last exposure.#### Management\n- Place a resident with a suspect/confirmed case, exposure, or a confirmed history of CPE (either through infection or colonization) on Contact Precautions as required. - For a CPE infection implement Contact Precautions and as per health authority guidelines. - For a CPE colonization implement Contact Precautions for direct care. - Discontinue additional precautions for residents with risk factors or exposure when screening is complete, based on health authority direction. - Notify physician/nurse practitioner and Infection Control Professional/Designate of any suspected and/or confirmed infections of CPE.",
      "char_count": 1093,
      "token_estimate": 273,
      "section_title": null,
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e_chunk_003_696b9b9e",
      "doc_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e",
      "chunk_index": 3,
      "text": "- Discontinue additional precautions for residents with risk factors or exposure when screening is complete, based on health authority direction. - Notify physician/nurse practitioner and Infection Control Professional/Designate of any suspected and/or confirmed infections of CPE. - Use the Multi-Drug-Resistant Organism Screening Algorithm and the MDRO Tracking Sheet to track surveillance testing of positive cases. - Ensure that cleaning/disinfecting of the resident’s room and washroom is completed with an appropriate chemical.### EDUCATION",
      "char_count": 546,
      "token_estimate": 136,
      "section_title": null,
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e_chunk_004_4542fae9",
      "doc_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e",
      "chunk_index": 4,
      "text": "1. IPC6-P10-E1 - MDRO Guide\n\n2. IPC6-P10-E5 - Carbapenemase Producing Enterobacterales (CPE) Fact Sheet----**Helping people live a better life.**\nThis document is uncontrolled when printed.\nExtendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025\n**Page 1 of 2**# PROCEDURE## SECTION: Multi-Drug-Resistant Organisms (MDROs)## DESCRIPTION: Carbapenemase-Producing Enterobacteriales (CPE)## INDEX: IPC6-P10-05### TOOLS",
      "char_count": 638,
      "token_estimate": 159,
      "section_title": "IPC6-P10-E1 - MDRO Guide",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e_chunk_006_379b72dd",
      "doc_id": "ipc6-p1005carbapenemaseproducingenterobacterales_5235dc541f7e",
      "chunk_index": 6,
      "text": "1. IPC6-P10-T3 – Multi-Drug-Resistant Organism Screening Algorithm - LTC ON\n\n2. IPC6-P10-T6 - CPE Risk Assessment----Helping people live betterThis document is uncontrolled when printed. Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025----**Page 2 of 2**",
      "char_count": 484,
      "token_estimate": 121,
      "section_title": "IPC6-P10-T3 – Multi-Drug-Resistant Organism Screening Algorithm - LTC ON",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    }
  ]
}